Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity

被引：7
|
作者：
Torras, J [1 ]
Figueras, J [1 ]
Lama, C [1 ]
Fabregat, J [1 ]
Ramos, E [1 ]
Rafecas, A [1 ]
Gil-Vernet, S [1 ]
Pares, D [1 ]
Busquets, J [1 ]
Jaurrieta, E [1 ]
机构：
[1] CSU Bellvitge, Liver Transplant Unit, Barcelona, Spain
来源：
TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(99)00462-5
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2430 / 2430
页数：1
相关论文
共 50 条
  • [31] Mycophenolate mofetil doses are too low in pediatric liver transplant recipients
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (2): : 64 - 64
  • [32] Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study
    Ahsan, N
    Hricik, D
    Matas, A
    Rose, S
    Tomlanovich, S
    Wilkinson, A
    Ewell, M
    McIntosh, M
    Stablein, D
    Hodge, E
    Hayes, D
    Gores, P
    Cohen, D
    Gonwa, T
    Brinler, K
    Harland, R
    Neylan, J
    Pescovitz, M
    Wynn, J
    Ahsan, N
    Yang, HC
    Bennett, W
    Copley, J
    Wilkinson, A
    Dunn, J
    Tomlanovich, S
    Chan, L
    Bertolatus, JA
    Weir, M
    Mendez, R
    Pirsch, J
    Helderman, JH
    TRANSPLANTATION, 1999, 68 (12) : 1865 - 1874
  • [33] Tacrolimus or cyclosporine:: Which is the better partner for mycophenolate-mofetil in heart transplant recipients?
    Meiser, BM
    Groetzner, J
    Kaczmarek, I
    Landwehr, P
    Müller, M
    Jung, S
    Überfuhr, P
    Fraunberger, P
    Stempfle, HU
    Weis, M
    Reichart, B
    TRANSPLANTATION, 2004, 78 (04) : 591 - 598
  • [34] Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil
    Paterson, DL
    Singh, N
    Panebianco, A
    Wannstedt, CF
    Wagener, MM
    Gayowski, T
    Marino, IR
    TRANSPLANTATION, 1998, 66 (05) : 593 - 598
  • [35] Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients
    Schrama, YC
    Joles, JA
    van Tol, A
    Boer, P
    Koomans, HA
    Hené, RJ
    TRANSPLANTATION, 2000, 69 (03) : 376 - 383
  • [36] Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Christensen, LL
    Molmenti, EP
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1563 - 1564
  • [37] Mycophenolate mofetil monotherapy in liver transplant recipients: A single center experience
    Fairbanks, KD
    Thuluvath, P
    LIVER TRANSPLANTATION, 2004, 10 (09) : 1189 - 1194
  • [38] Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients
    Esmeraldo, RM
    Donadi, MORC
    Oliveira, ML
    Ponte, CN
    Pinheiro, PMA
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (07) : 3007 - 3008
  • [39] Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine
    Fabrega, AJ
    Corwin, CL
    Hunsicker, L
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1562 - 1563
  • [40] Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function
    Liu, B
    Lin, ZB
    Ming, CS
    Zhang, WJ
    Chen, ZS
    Sha, B
    Zeng, FJ
    Chen, S
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 87 - 88
12345